Page last updated: 2024-08-22

pimozide and Breast Neoplasms

pimozide has been researched along with Breast Neoplasms in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (42.86)18.2507
2000's0 (0.00)29.6817
2010's2 (28.57)24.3611
2020's2 (28.57)2.80

Authors

AuthorsStudies
Ghosh, SS; Kandasamy, T; Sen, P1
Ji, YX; Li, J; Liu, SP; Qu, P; Yuan, S; Zhang, QG; Zhou, XZ1
Bu, W; Camacho, L; Garcia, S; Hein, S; Hilsenbeck, SG; Johnston, AN; Kapali, J; Li, Y; Nagi, C; Nangia, J; Podsypanina, K; Qin, L; Xue, L1
Al-Omaishi, S; Celebre, A; Chan, J; Das, S; Dirks, PB; Ghannad-Zadeh, K; Guan, J; Isaev, K; Kaskun, O; Moran, MF; Morrissy, AS; Munoz, DG; Reimand, J; Sachdeva, R; Smiljanic, S; Taylor, MD; Tong, J; Wilson, TM; Wu, M1
Hylton, H; Melkoumian, Z; Peterson, VA; Strobl, JS1
Peterson, VA; Strobl, JS1
Kirkwood, KL; Lantz, TK; Lewine, MA; Peterson, VA; Strobl, JS; Worley, JF1

Other Studies

7 other study(ies) available for pimozide and Breast Neoplasms

ArticleYear
Multi-targeted Drug Repurposing Approach for Breast Cancer via Integrated Functional Network Analysis.
    Molecular informatics, 2022, Volume: 41, Issue:8

    Topics: Breast Neoplasms; Cell Line, Tumor; Drug Repositioning; Epithelial-Mesenchymal Transition; Female; Humans; Molecular Docking Simulation; Pimozide

2022
Pimozide inhibits the growth of breast cancer cells by alleviating the Warburg effect through the P53 signaling pathway.
    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2022, Volume: 150

    Topics: Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Female; Glycolysis; Humans; Phosphatidylinositol 3-Kinases; Pimozide; Proto-Oncogene Proteins c-akt; Signal Transduction; Tumor Suppressor Protein p53

2022
Hyperprolactinemia-inducing antipsychotics increase breast cancer risk by activating JAK-STAT5 in precancerous lesions.
    Breast cancer research : BCR, 2018, 05-19, Volume: 20, Issue:1

    Topics: Animals; Antipsychotic Agents; Apoptosis; Breast; Breast Neoplasms; Cell Differentiation; Female; Humans; Hyperprolactinemia; Janus Kinase 2; Mice; Pimozide; Precancerous Conditions; Risk Factors; Risperidone; Signal Transduction; STAT5 Transcription Factor

2018
ID1 Is Critical for Tumorigenesis and Regulates Chemoresistance in Glioblastoma.
    Cancer research, 2019, 08-15, Volume: 79, Issue:16

    Topics: Animals; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Breast Neoplasms; Drug Resistance, Neoplasm; ErbB Receptors; Female; Gene Expression Regulation, Neoplastic; Glioblastoma; Humans; Inhibitor of Differentiation Protein 1; Melanoma; Mice, Inbred NOD; Phosphorylation; Pimozide; Temozolomide; Xenograft Model Antitumor Assays

2019
The cell death response to gamma-radiation in MCF-7 cells is enhanced by a neuroleptic drug, pimozide.
    Breast cancer research and treatment, 1998, Volume: 51, Issue:1

    Topics: Antipsychotic Agents; Apoptosis; Breast Neoplasms; Cell Division; Female; Flow Cytometry; Gamma Rays; Guanidines; Haloperidol; Humans; Pimozide; Radiation-Sensitizing Agents; Tumor Cells, Cultured

1998
Tamoxifen-resistant human breast cancer cell growth: inhibition by thioridazine, pimozide and the calmodulin antagonist, W-13.
    The Journal of pharmacology and experimental therapeutics, 1992, Volume: 263, Issue:1

    Topics: Breast Neoplasms; Calmodulin; Cell Cycle; Cell Division; Drug Resistance; Flow Cytometry; Humans; Pimozide; Receptors, Estrogen; Sulfonamides; Thioridazine; Tumor Cells, Cultured

1992
Inhibition of human breast cancer cell proliferation in tissue culture by the neuroleptic agents pimozide and thioridazine.
    Cancer research, 1990, Sep-01, Volume: 50, Issue:17

    Topics: Antineoplastic Agents; Breast Neoplasms; Cell Division; Cell Line; DNA Replication; Estradiol; Female; Humans; Kinetics; Pimozide; Thioridazine; Thymidine; Tumor Cells, Cultured

1990